A preliminary attempt to personalize risperidone dosing using drug-drug interactions and genetics: Part I

Psychosomatics

Volumn 49, Issue 3, 2008, Pages 258-270

  De Leon, Jose ^a   Sandson, Neil B ^b   Cozza, Kelly L ^b  

^a EASTERN STATE HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; DOPAMINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; HISTAMINE RECEPTOR; MIRTAZAPINE; NEUROTRANSMITTER RECEPTOR; PLACEBO; RISPERIDONE; RITANSERIN; SEROTONIN; SEROTONIN RECEPTOR;

BIPOLAR MANIA; CLINICAL TRIAL; COMPREHENSION; DRUG DOSE TITRATION; DRUG INTERACTION; DRUG MECHANISM; DRUG RESPONSE; DRUG SAFETY; ENVIRONMENT; EXTRAPYRAMIDAL SYMPTOM; GENETIC VARIABILITY; GENETICS; HUMAN; HYPERPROLACTINEMIA; KNOWLEDGE; MENTAL DISEASE; NONHUMAN; PHARMACODYNAMICS; PREDICTION; REVIEW; SCHIZOPHRENIA; SOMNOLENCE;

EID: 43449101550     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.49.3.258     Document Type: Article

References (95)